Added to YB: 2025-04-23
Pitch date: 2025-04-21
4BB.L [neutral]
4basebio PLC
-43.11%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
Market Cap
GBP 144.1M
Pitch Price
GBP 11.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-16.51
P/E
-14.31
EV/Sales
263.15
Sector
Biotechnology
Category
N/A
Exploring AIM: A-Z Part 1 - 4basebio PLC
4BB.L pass: £180M unprofitable biotech at >100x sales. Recent catalysts: UK manufacturing certification, new CCO appointed, RBC coverage initiated. Something's happening but biotech knowledge needed.
Read full article (1 min)